UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Terminated
Unique ID issued by UMIN UMIN000004319
Receipt No. R000005176
Scientific Title Clinical pharmacological study of [11C]S-dThd reflecting DNA synthesis rate
Date of disclosure of the study information 2010/10/04
Last modified on 2012/12/21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical pharmacological study of [11C]S-dThd reflecting DNA synthesis rate
Acronym Clinical pharmacological study of [11C]S-dThd
Scientific Title Clinical pharmacological study of [11C]S-dThd reflecting DNA synthesis rate
Scientific Title:Acronym Clinical pharmacological study of [11C]S-dThd
Region
Japan

Condition
Condition Cancer
Classification by specialty
Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To confirm safety of [11C] S-dThd, to analyze the pharmacokinetics, to estimate the exposure dose, and to evaluate the tumor accumulation.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Safety, pharmacokinetics, exposure dose, and tumor accumulation
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 [11C] S-dThd PET/CT
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
50 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Untreated cancer patients
Key exclusion criteria - Severe heart disease (&#8805; NYHA class II)
- Severe renal dysfunction
- Performance Status (PS)&#8805;2; intolerable to PET scanning
- Lack in ability to give an informed consent
- Patients regarded as unsuitable by responsible investigators
Target sample size 6

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Tsuneo Saga
Organization National Institute of Radiological Sciences
Division name Molecular Imaging Center
Zip code
Address 4-9-1 Anagawa Inage, Chiba
TEL
Email

Public contact
Name of contact person
1st name
Middle name
Last name
Organization National Institute of Radiological Sciences
Division name Molecular Imaging Center
Zip code
Address 4-9-1 Anagawa Inage, Chiba
TEL
Homepage URL
Email

Sponsor
Institute National Institute of Radiological Sciences
Institute
Department

Funding Source
Organization National Institute of Radiological Sciences
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2010 Year 10 Month 04 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2010 Year 07 Month 28 Day
Date of IRB
Anticipated trial start date
2010 Year 12 Month 02 Day
Last follow-up date
2011 Year 02 Month 03 Day
Date of closure to data entry
2012 Year 04 Month 05 Day
Date trial data considered complete
2012 Year 04 Month 05 Day
Date analysis concluded
2012 Year 04 Month 05 Day

Other
Other related information

Management information
Registered date
2010 Year 10 Month 04 Day
Last modified on
2012 Year 12 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005176

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.